Budemet 200 Convicap is an inhalation capsule produced by Incepta Pharmaceuticals Ltd., combining two active ingredients: Budesonide (200 µg), a corticosteroid that reduces inflammation in the airways, and Formoterol Fumarate Dihydrate (6 µg), a long-acting bronchodilator that relaxes airway muscles. This combination is utilized for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD)